Neuronetics, Inc. Common Stock
$2.90
-$0.07 (-2.36%)
$2.85Day Range$3.04
Key Statistics
Market Cap
$220.97M
Shares Outstanding
76.2M
Primary Exchange
XNAS
Currency
USD
Type
CS
IPO Date
Jun 28, 2018
Round Lot
100
Locale
US
Trading Data
Day Open
$2.92
Day High
$3.04
Day Low
$2.85
Volume
1.12M
VWAP
$2.91
Prev Close
$2.97
Transactions
--
Acc. Volume
--
About Neuronetics, Inc. Common Stock
Neuronetics Inc a commercial-stage medical technology company focused on designing, developing, and marketing products that improve the quality of life for patients who suffer from psychiatric disorders. Its first commercial product, the NeuroStar Advance Therapy System, is a non-invasive and non-systemic office-based treatment that uses transcranial magnetic stimulation, or TMS, to create a pulsed, MRI-strength magnetic field that induces electrical currents designed to stimulate specific areas of the brain associated with mood. The company designed the NeuroStar Advance Therapy as a non-invasive therapeutic alternative to treat patients who suffer from MDD and to address the existing treatment options. The company operates in two segments: medical devices and clinic services.
SURGICAL & MEDICAL INSTRUMENTS & APPARATUSSIC 3841658 employees3222 PHOENIXVILLE PIKE, MALVERN, PA, 19355877-600-7555IPO Jun 28, 2018US / STOCKSActiveWebsite
Identifiers
- CIK
- 0001227636
- Composite FIGI
- BBG000QX36J1
- Share Class FIGI
- BBG001SSSWY7
- Ticker Root
- STIM
- SIC Code
- 3841
About Neuronetics, Inc. Common Stock (STIM) Stock
Neuronetics, Inc. Common Stock (STIM) closed the 2026-09-18 session at $2.90, down 2.36% versus the previous close (-0.07). The stock opened at $2.92 and traded between $2.85 and $3.04 during that session. Session trading volume was 1.1M shares. The volume-weighted average price (VWAP) is $2.91.
Neuronetics Inc a commercial-stage medical technology company focused on designing, developing, and marketing products that improve the quality of life for patients who suffer from psychiatric disorders. Its first commercial product, the NeuroStar Advance Therapy System, is a non-invasive and non-systemic office-based treatment that uses transcranial magnetic stimulation, or TMS, to create a pulsed, MRI-strength magnetic field that induces electrical currents designed to stimulate specific areas of the brain associated with mood. The company designed the NeuroStar Advance Therapy as a non-invasive therapeutic alternative to treat patients who suffer from MDD and to address the existing treatment options. The company operates in two segments: medical devices and clinic services.
Neuronetics, Inc. Common Stock has a market capitalization of $221.0 million. The company operates in the SURGICAL & MEDICAL INSTRUMENTS & APPARATUS industry classification. STIM is listed on the XNAS exchange. The company employs approximately 658 people. Neuronetics, Inc. Common Stock is headquartered in MALVERN, PA. The recorded listing date is 2018-06-28.
On this page you can find market STIM stock price data, interactive price charts with multiple timeframes (1 day to max history), company financials including income statements, balance sheets, and cash flow statements, technical indicators (SMA 50, SMA 200, EMA 20, MACD, RSI), latest news and sentiment analysis, dividend history, stock splits, short interest data, float information, and related stocks.
Explore more: View today's market movers, use the stock screener, or browse all sectors. See more stocks in the SURGICAL & MEDICAL INSTRUMENTS & APPARATUS sector.